FDAFebruary 12, 2021device

Valiant Navion Thoracic Stent Graft System. For endovascular repair of lesions in the descending thoracic aorta (DTA).

Official recall recorded by the U.S. Food & Drug Administration.

The hazard

Due to the presence of type IIIb endoleaks, stent fractures, and stent ring enlargement.

What to do

FDA enforcement status: Ongoing

Brands named

medtronic vascularmedtronic

UPCs

007630001005200076300010053700763000100544007630001005510076300010056800763000100575007630001005820076300010059900763000100605007630001006120076300010062900763000100636

Recall history

Other federal recalls tied to the same brand — a factual pattern, straight from the source data.

Own something like this?

AllClear screens your whole list against every CPSC, FDA, USDA and NHTSA recall — and tells you the day a new one names something you own.

Start free — 200 items, no card →
Valiant Navion Thoracic Stent Graft System. For endovascular repair of lesions in the descending thoracic aorta (DTA). — Recall Details · AllClear